(1)
Lin, W.; Lin, Z.; Zhang, M. The Therapy of Osimertinib for EGFR Mutation—Non-Small Cell Lung Cancer. HSET 2022, 6, 219-229. https://doi.org/10.54097/hset.v6i.964.